Approach to haemangiomatosis causing congestive heart failure

Roie Tal, Moshe Dotan, Avraham Lorber

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Haemangiomas represent the most common tumour of infancy. Although most cases are cutaneous benign lesions, multiple skin haemangiomas are associated with visceral involvement, especially of the liver. Hepatic haemangiomatosis may be complicated by high-output cardiac failure due to high-flow arteriovenous connections within the lesions. Different therapeutic strategies for treating haemangiomatosis causing heart failure include medical, surgical and interventional modalities. This study aimed to review the treatment options, discuss their benefits and flaws and propose a practical therapeutic approach for this medical situation. Conclusion Our approach incorporates heart failure medications, dietary support and propranolol as first-line treatment, while corticosteroids, vincristine, percutaneous intervention and surgery are reserved for refractory cases.

Original languageEnglish
Pages (from-to)600-604
Number of pages5
JournalActa Paediatrica, International Journal of Paediatrics
Issue number6
StatePublished - 1 Jun 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2016 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd.


  • Haemangioma
  • Haemangiomatosis
  • Heart failure
  • Liver
  • Propranolol


Dive into the research topics of 'Approach to haemangiomatosis causing congestive heart failure'. Together they form a unique fingerprint.

Cite this